AUA 2018 Prostate Cancer
Viewing 41-60 of 109 articles
AUA 2018: Which Patients with Clinically Node Positive Prostate Cancer Benefit from Radical Prostatectomy?
AUA 2018: Using Multi-parametric Magnetic Resonance Imaging and Targeted Biopsy to Rule Out Seminal Vesicle Invasion in Prostate Cancer
AUA 2018: Correlation Between Genomic Index Lesions, Multi-parametric MRI and 68Ga-PSMA-PET/CT Imaging Features in Primary Prostate Cancer
AUA 2018: Early Experience of a Randomized Controlled Trial of Radical Prostatectomy for Oligo-Metastatic Prostate Cancer: Challenges to Patient Recruitment and Effective Solutions
AUA 2018: The First Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Men Staged with mpMRI for Clinically Localized Prostate Cancer
AUA 2018: Interim Analysis of an Open Label Phase II Study of Enzalutamide and Radium-233 in Symptomatic, mCRPC
AUA 2018: Statin Use is Associated with Improved Prostate Cancer-Specific Outcomes in White but Not Black Men Initiating ADT
AUA 2018: Superior Efficacy of Degarelix as Neoadjuvant Hormone Therapy in Control of Acute Genitourinary Toxicity Associated with Radiation Therapy for Prostate Cancer
AUA 2018: Salvage High-Intensity Focused Ultrasound For Locally Recurrent Prostate Cancer after Low-Dose-Rate Brachytherapy: Oncologic and Functional Outcomes
AUA 2018: Patient Reported Outcomes in SPARTAN, a Phase 3, Double-Blind, Randomized Study of Apalutamide plus ADT vs placebo plus ADT in Men with nmCRPC
AUA 2018: Can Active Surveillance Really Reduce the Harms of PSA Testing? PRIAS-Study Implicates Caution
AUA 2018: Long-Term Outcomes of Active Surveillance for Prostate Cancer - Memorial Sloan Kettering Cancer Center Experience
AUA 2018: Effect of Selection and Referral Biases for the Treatment of Localized Prostate Cancer with Surgery or Radiation
AUA 2018: Can Free PSA Be Used as a Biomarker in Biochemical Recurrence after Surgery to Predict Castration Resistant Prostate Cancer?
AUA 2018: Risk of Men with Intermediate Risk Prostate Cancer Going On To Definitive Treatment During Active Surveillance: Does a High PSA Predict a Worse Outcome?